Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015
By A. Cohen, M. Brauer, R. Burnett, R. Anderson, J. Frostad, Kara Estep, K. Balakrishnan, B. Brunekreef, L. Dandona, R. Dandona and 20 more. The Lancet, 2017
5,223 citations recorded by the source corpus.
Summary Background Exposure to ambient air pollution increases morbidity and mortality, and is a leading contributor to global disease burden. We explored spatial and temporal trends in mortality and burden of disease attributable to ambient air pollution from 1990 to 2015 at global, regional, and country levels. Methods We estimated global population-weighted mean concentrations of particle mass with aerodynamic diameter less than 2·5 μm (PM2·5) and ozone at an approximate 11 km × 11 km resolution with satellite-based estimates, chemical transport models, and ground-level measurements. Using integrated exposure–response functions for each cause of death, we estimated the relative risk of mortality from ischaemic heart disease, cerebrovascular disease, chronic obstructive pulmonary disease, lung cancer, and lower respiratory infections from epidemiological studies using non-linear exposure–response functions spanning the global range of exposure. Findings Ambient PM2·5 was the fifth-ranking mortality risk factor in 2015. Exposure to PM2·5 caused 4·2 million (95% uncertainty interval [UI] 3·7 million to 4·8 million) deaths and 103·1 million (90·8 million 115·1 million) disability-adjusted life-years (DALYs) in 2015, representing 7·6% of total global deaths and 4·2% of global DALYs, 59% of these in east and south Asia. Deaths attributable to ambient PM2·5 increased from 3·5 million (95% UI 3·0 million to 4·0 million) in 1990 to 4·2 million (3·7 million to 4·8 million) in 2015. Exposure to ozone caused an additional 254 000 (95% UI 97 000–422 000) deaths and a loss of 4·1 million (1·6 million to 6·8 million) DALYs from chronic obstructive pulmonary disease in 2015. Interpretation Ambient air pollution contributed substantially to the global burden of disease in 2015, which increased over the past 25 years, due to population ageing, changes in non-communicable disease rates, and increasing air pollution in low-income and middle-income countries. Modest reductions in burden will occur in the most polluted countries unless PM2·5 values are decreased substantially, but there is potential for substantial health benefits from exposure reduction. Funding Bill & Melinda Gates Foundation and Health Effects Institute.
Subfields: Global and Planetary Change, Health, Toxicology and Mutagenesis
View Paper: https://www.semanticscholar.org/paper/3d1530e016e349526e6830af922e001578873166
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Global and Planetary Change
In Health, Toxicology and Mutagenesis
Citations in the corpus
- Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease (2019, background): “The upward trend in diabetic prevalence is exemplified in the recent update to the GBD, which shows that diabetes and related metabolic diseases have increased in prevalence and incidence between 1990 and 2015 [17].”
- Built environmental correlates of older adults’ total physical activity and walking: a systematic review and meta-analysis (2017, background): “Beyond facilitating PA, it is plausible that there are synergistic benefits of streetscape trees and vegetation, for example, in reducing urban heat island effect [103] and air pollution [104] – environmental factors linked with premature mortality [105] and global disease burden [106].”
- Severe haze in northern China: A synergy of anthropogenic emissions and atmospheric processes (2019, background): “There has been accumulating evidence that exposure to fine PM causes acute and chronic diseases (21, 22).”